Arvinas, Inc.

ARVN Stock Healthcare Biotechnology
$9.18
-0.06 (-0.65%)
Price as of Aug 28, 2026 market close

Performance

1 Month
+10.6%
3 Months
+2.2%
YTD
-22.6%
1 Year
+13.6%

Price return, based on split- and dividend-adjusted closing prices.

Risk

Volatility 1-year annualized
54.6%
Largest decline max drawdown, since Aug 2025
-49.5%
Risk-adjusted return Sharpe ratio, 1-year
0.50

Own ARVN?

See how ARVN contributes to your portfolio's return, allocation, and risk.

7-day free trial, then $9/month.